AdipoSight.ai is an A*STAR spin-off from the Singapore BioImaging Consortium (SBIC), on a mission to improve metabolic health assessment. AdipoSight.ai is positioned to deliver a new level of insight into disorders of fat metabolism, improving our understanding and treatment of obesity, diabetes and fatty liver disease, and knock-on effects to heart disease and breast cancer. AdipoSight.ai is realising this vision through clinical development of fatty acid composition (FAC) imaging, building on artificial intelligence augmentation of quantitative magnetic resonance imaging techniques. As a purely digital technology, fatty acid composition imaging is primed for telehealth delivery in the cloud direct to you.
From Singapore to the world, AdiposSight.ai has your metabolic health, envisioned.